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Abstract
Nectin-like molecule-2 (Necl-2), a junction molecule, is exclusively expressed by spermatogenic cells. It mediates homophilic
interaction between germ cells and heterophilic interaction between Sertoli and germ cells. Knockout studies have shown
that loss of Necl-2 causes male infertility, suggesting Necl-2-based cell adhesion is crucial for spermatogenesis. Transforming
growth factor-bs (TGF-bs) are crucial for regulating cell junction restructuring that are required for spermatogenesis. In the
present study, we aim to investigate the mechanism on how TGF-b1 regulates Necl-2 expression to achieve timely junction
restructuring in the seminiferous epithelium during spermatogenesis. We have demonstrated that TGF-b1 reduces Necl-
2 mRNA and protein levels at both transcriptional and post-translational levels. Using inhibitor and clathrin shRNA, we have
revealed that TGF-b1 induces Necl-2 protein degradation via clathrin-dependent endocytosis. Endocytosis assays further
confirmed that TGF-b1 accelerates the internalization of Necl-2 protein to cytosol. Immunofluorescence staining also
revealed that TGF-b1 effectively removes Necl-2 from cell-cell interface. In addition, TGF-b1 reduces Necl-2 mRNA via down-
regulating Necl-2 promoter activity. Mutational studies coupled with knockdown experiments have shown that TGF-b1-
induced Necl-2 repression requires activation of Smad proteins. EMSA and ChIP assays further confirmed that TGF-b1
promotes the binding of Smad proteins onto MyoD and CCAATa motifs in vitro and in vivo. Taken together, TGF-b1 is a
potent cytokine that provides an effective mechanism in controlling Necl-2 expression in the testis via Smad-dependent
gene repression and clathrin-mediated endocytosis.
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Introduction
During spermatogenesis, developing germ cells must migrate
from the basal to the adluminal compartment, which requires the
disassembly and reassembly of cell junctions between Sertoli cells
and developing germ cells [1]. This not only allows progressive
movement of developing germ cells along the seminiferous
epithelium, but also reattachment of germ cells to adjacent Sertoli
cells via cell junctions provides physical support for germ cells.
Our and other laboratories have identified several signaling
pathways that are involved in the regulation of cell junction
restructuring in the testis. In fact, cross-talk between signaling
molecules and different regulatory levels including transcriptional,
post-transcriptional and post-translational modification of cell
junction proteins mediated by hormones and cytokines are crucial
for the precise control of cell junction restructuring [2–4].
Cell junctions between Sertoli and germ cells are constituted by
different types of junction protein complexes such as nectin-afadin
and JAM-ZO-1 protein complexes [5,6]. Recent animal studies
have shown that knockout of individual junction proteins,
including nectin-2, nectin-3, or JAM-C cause infertility in male
mice, indicating that each of the protein components indeed plays
an indispensable role in cell adhesion during spermatogenesis [7–
10]. Nectin-like molecule-2 (Necl-2) belongs to immunoglobulin
superfamily. It has been also known as IGSF4A/TSLC1/RA175/
SgIGSF/SynCAM/CADM1 due to its diverse functions in various
tissues [11–16]. Necl-2 contains three immunoglobulin-like loops
in the extracellular domain, a transmembrane domain and a
cytoplasmic tail. In the testis, Necl-2 is exclusively expressed by
spermatogenic cells. Detailed immunohistochemical analysis has
indicated that Necl-2 is expressed in intermediate spermatogonia
to early pachytene spermatocytes, and reappears in step 7 and late
spermatids [17]. Recent studies have revealed that Necl-2 is also
detected in several type A spermatogonia and step 5–6 spermatids
[18]. Necl-2 mediates homophilic interaction between spermato-
genic cells, as well as heterophilic interaction between Sertoli and
germ cells [17,19]. Studies have confirmed that Necl-2 on
spermatogenic cells interacts with Necl-5 (PVR/CD155/Tage4)
that is expressed on Sertoli cells [19]. Like other junction proteins,
knockout studies have shown that Necl-2 null male mice are
sterile, and display defects in spermatogenesis with reduced sperm
motility and abnormal morphology of spermatids [20–23]. A
significant reduction in the number of mature spermatids has been
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reported in the knockout mice. It is due to severe cell sloughing
from the seminiferous epithelium and the disruption of the
intercellular cytoplasmic bridge between germ cells. Apparently,
Necl-2 is essential for adhesion between spermatogenic cells as well
as between Sertoli cells and spermatogenic cells.
Transforming growth factor-b family is known to regulate
junction restructuring required for spermatogenesis. For instance,
TGF-b3 perturbs the blood-testis barrier (BTB) integrity, the
apical ectoplasmic specialization and AJ by altering the expression
of TJ and AJ proteins, such as occludin and N-cadherin [24–26].
Recent studies have suggested that TGF-b2 down-regulates JAM-
B expression via transcriptional regulation in Sertoli cells [4].
Moreover, it accelerates the internalization of junction molecules
such as JAM-A at the cell-cell interface and induces protein
degradation via endocytosis [27]. Immunohistochemical analyses
reveal that both Sertoli and germ cells express TGF-b1 in rat
testes. The level of TGF-b1 is predominant in spermatocytes and
early round spermatids at stage VIII and IX of epithelial cycle,
and immunoreactivity declines rapidly thereafter [28,29]. This
unique expression pattern of TGF-b1 suggests that it might involve
in the regulation of junction dynamics in the testis. In this study,
we aim to investigate the potential mechanisms of how TGF-b1
regulates Necl-2 expression in germ cells that may allow timely
release of mature germ cells from the epithelium to the lumen by
disrupting cell junctions between germ cells. We herein report that
TGF-b1 reduces Necl-2 level by Smad-mediated Necl-2 gene
repression and clathrin-dependent endocytosis of Necl-2 protein
from cell-cell interface.
Materials and Methods
Cells Culture and Treatment
GC-1 spg cells (mouse germ cell line) were obtained from
American Type Culture Collection (Manassas, VA). Cells were
grown in DMEM (Invitrogen, Carlsbad, CA) containing 10%
FBS. Cultures were maintained at 37uC in humidified atmosphere
with 5% CO2 in air. For mRNA stability experiments, cells were
pre-treated with actinomycin D (5 mg/ml) for 2 h before vehicle
(4 mM HCl/0.1%BSA) or TGF-b1 (5 ng/ml) treatment. For post-
translational studies, cells were pre-treated with cycloheximide
(5 mg/ml, 30 min) followed by inhibitors for 30 min to 1.5 h
before the addition of TGF-b1.
Antibodies and Reagents
Antibody against Necl-2 (Code No. CM004–3) for Western
blotting was obtained from MBL International Corporation
(Woburn, MA). Anti-Necl-2 (S4945) for immunofluorescence
microscopy was purchased from Sigma-Aldrich (St. Louis, MO).
Anti-Smad2/3 (sc-8332X), anti-Smad4 (sc-7154X), anti-MyoD
(sc-760X) and anti-NF-1 (sc-870) antibodies for EMSA were from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-Smad3 (Cat
no. 51–1500) and anti-Smad4 (sc-7966) for Western blotting were
from Zymed Laboratories (South San Francisco, CA) and Santa
Cruz Biotechnology, respectively. Antibody against clathrin (Cat
no. 610499) was from BD Biosciences (San Jose, CA). Transform-
ing growth factor-b1, actinomycin D (ActD), nystatin, chlopro-
mazine (CPZ) and MG132 were purchased from Calbiochem (San
Diego, CA). Cycloheximide (CHX) was from Sigma-Aldrich.
Smad3 and Smad4 siRNAs were purchased from Dharmacon
(Lafayette, CO). Clathrin shRNAs (TG516542) and control
plasmids were from Origene Technologies (Rockville, MD). The
target sequences of siRNAs and shRNAs were listed in Table 1.
Construction of Necl-2 Promoter-luciferase Plasmids and
Site-directed Mutagenesis
The 59-flanking region of the Necl-2 gene was generated by
PCR amplification using gene-specific primers (Table 2) and
mouse genomic DNA. Progressive 59-deleted regions generated by
PCR were cloned into pGL-3 Basic vector (Promega Corp.,
Madison, WI). Mutant constructs were generated by a three-step
PCR mutagenesis using mutagenic primers (Table 2) as described
in the previous studies [30]. All plasmids were prepared by
Plasmid Midi Kits (Qiagen, Chatsworth, CA) and confirmed by
sequencing analysis.
Semi-quantitative RT-PCR and Quantitative Real-time
PCR
Total RNA was isolated from GC-1spg cells using TRIZOL
reagent (Invitrogen) and reverse transcribed with Moloney murine
leukemia virus reverse transcriptase kit (Invitrogen). RT products
were used as templates for subsequent PCR with a pair of Necl-2
and b-actin primers, respectively (Table 2). Co-amplifications of
Necl-2 and b-actin were in their linear phases. The authenticity of
the PCR product was confirmed by sequencing analysis. The gel
images were captured and analyzed using Quantity One 1-D
analysis software (Bio-Rad Laboratories, Hercules, CA). For Real-
time PCR, the mRNA level of Necl-2 was analyzed by the 7300
Real Time PCR system (Applied Biosystems, Foster City, CA)
with Power SYBR Green Master Mix (Applied Biosystems)
according to the manufacturer’s instructions (n = 3, each in
triplicate). The GAPDH was used as an internal control for
normalization. The specificity of the fluorescence signal was
confirmed by both melting curve analysis and agarose gel
electrophoresis. The expression level of the target gene was
determined using 22ggCT method.
Transfection and Luciferase Reporter Assays
GC-1 spg cells (1.36104 cells/cm2) were seeded onto a 12-well
plate one day before transfection. Luciferase constructs (0.5 mg)
and pEGFP vector (0.1 mg) were co-transfected using GeneJuice
transfection reagent (Novagen, Madison, WI). Luciferase activity
was detected at 48 h post-transfection using a PerkinElmer 2030
multilabel reader (PerkinElmer, Waltham, MA). pEGFP activity
was determined by CytoFluor multiwell plate reader (PerSeptive
Biosystems, Framingham, MA) and used to normalize transfection
efficiency. For Smad3/4 knockdown experiment, luciferase
constructs (0.5 mg) and pEGFP vector (0.1 mg) were co-transfected
with si-Smad3 (20 nM) or/and si-Smad4 (20 nM) using Lipofec-
tamine 2000 transfection reagent (Invitrogen). For shRNA or
siRNA experiments, two different target sequences for the gene
were used to rule out the off-target effects.
Table 1. siRNAs and shRNAs used for different knockdown
experiments in this study.
Target gene Sequence (59-39) Catalog no.
Smad3 #1 GAA CUU ACA AGG CGA CAC A J-040706-05
Smad3 #2 CCA UGG AGC UCU GUG AGU U J-040706-07
Smad4 #1 UCA GGU GGC UGG UCG GAA A J-040687-05
Smad4 #2 GCA AUU GAG AGU UUG GUA A J-040687-07
Clathrin #1 GAC CAA TCT CAG CAG ACA GTG CCA
TCA TG
TG516542
Clathrin #2 TCA GTT GCC ACT TAT CAT TGT CTG TGA TC TG516542
doi:10.1371/journal.pone.0064316.t001
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Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extracts were prepared as described previously [4].
Double–stranded oligonucleotides containing MyoD or CCAATa
motifs were end-labeled with [c-32P]ATP (PerkinElmer) by using
T4 kinase (Invitrogen). EMSA was performed in 20 ml reaction
mixture containing 20 mM HEPES (pH 7.6), 50 mM NaCl,
1.5 mM MgCl2, 1 mM DTT, 1 mM EDTA, 10% glycerol, 1 mg
poly (dI:dC), radiolabeled probe (100,000 cpm) and nuclear
extract (1–15 mg). For competition assay, unlabeled oligonucleo-
tides (100–500x) were added to the reaction as competitors. For
supershift assay, EMSA reaction mixture was further incubated
with specified antibodies (6 mg) or serum at room temperature for
30 min before gel electrophoresis. The reaction products were
separated on a 5% polyacrylamide gel. The gels were dried and
then exposed to X-ray film at 270uC overnight.
Western Blotting
Protein extracts from GC-1 spg cells were prepared in IP lysis
buffer (50 mM Tris, 0.15 M NaCl, 2 mM EDTA, 2 mM PMSF,
1% NP-40 and 10% glycerol [v/v], pH 7.4 at 22uC). Total
protein concentration was determined by Bradford assay (Bio-
Rad). Protein extracts were resolved on a polyacrylamide gel,
transferred onto nitrocellulose membrane (Bio-Rad) and blocked
with 5% non-fat milk powder [w/v] in PBS/Tris/0.1% Tween-20
for 1 h. Membrane was incubated with an appropriate primary
antibody at 4uC overnight, followed by incubation of correspond-
ing secondary antibody (Santa Cruz Biotechnology) for 1 h. ECL
Western blotting detection reagents (GE Healthcare, Buckingham-
shire, UK) were used for protein detection. The X-ray films were
scanned and bands were analyzed by Quantity One 1-D analysis
software (Bio-Rad).
Chromatin Immunoprecipitation (ChIP) Assay
Chromatin immunoprecipitation (ChIP) assay was conducted
using EZ-ChIP kit (Millipore Corp., Billerica, MA). GC-1 spg cells
(1.36104 cells/cm2) were seeded onto a 12-well plate. TGF-b1 was
added at 18 h before harvest. Lysates were sonicated with Sonifier
450 (Branson, Danbury, CT). Precleared lysates were incubated
with antibodies (2 mg) or rabbit serum (2 mg) at 4uC overnight.
Protein G agarose with protein/DNA complexes were washed and
reversed to free DNA at 65uC for 5 h. DNA was purified using
spin columns and analyzed by PCR using specific primers
(Table 2).
Endocytosis Assay
GC-1 spg cells (1.36104 cells/cm2) were seeded onto 60-mm
dishes 4 days before treatment. Cells were washed twice with ice-
cold PBS, incubated with Sulfo-NHS-SS-Biotin (0.5 mg/ml)
(Thermo Fisher Scientific, Hudson, NH) in PBS/CM (PBS
containing 0.9 mM CaCl2 and 0.33 mM MgCl2) at 4uC for
Table 2. Nucleotide sequence of primers used in RT-PCR, plasmid construction, EMSA, ChIP.
Primer name Location Direction Sequence (59-39) Purpose
A107 +285/+304 S GAA GGA CAG CAG GTT TCA GC RT-PCR/ChIP
A108 +702/+721 AS CTA GAT AGC GCT GGG TCT GC RT-PCR/ChIP
b-actin +314/+337 S TCA CCG AGG CCC CTC TGA ACC CTA RT-PCR
b-actin +934/+957 AS GGC AGT AAT CTC GTT CTG CAT CCT RT-PCR
A141 219/21 AS ATG AAG CTT GTC GGG CAC CTG CCT CAG A Deletion
A142 2268/2245 S ATA CGC GTG GAA GCG AGG CCG AAT TTT AAC GT Deletion
A143 2502/2477 S ATA CGC GTG CAA GGT GAG GGA AAG GAA ATT TTG T Deletion
A144 21029/21003 S ATA CGC GTC TCT GAG ACA CAA CTA AAG TGA GGA CC Deletion
A158 2159/2140 S ATA CGC GTT GGG GGA GGG GGC TAG TCC T Deletion
MP-B S GGA GTA CTA ACC CTG GCC TAG CAA AAT AGG CTG TCC C Universal primer
MP-C AS GGG CCC TTC TTA ATG TTT TTG GC Universal primer
MP-D S GGA GTA CTG ACC CTG GC Universal primer
A 174 MYOD* AS ATG AAG CTT GTC GGG CAC tct CCT CAG A Mutation
A175 CCAATa* AS CGG ACA GCT cgg GAG ATG Mutation
A177 CCAATb* AS GAG CGA Cac cTC GTG GC Mutation
A256 S TCT GAG GCA GGT GCC CGA C EMSA
A257 AS GTC GGG CAC CTG CCT CAG A EMSA
A258 S TAG CAT CTC ATT AGC TGT CCG CT EMSA
A259 AS AGC GGA CAG CTA ATG AGA TGC TA EMSA
A287 2349/2329 S GAG AGA CCC GCC TCC TGA AGC ChIP
A288 222/21 AS GTC GGG CAC CTG CCT CAG ACT ChIP
A400 +242/+261 S ACA ACA GCA CCC GCG ACC GG RT-PCR
A401 +928/+948 GCC CTT GGG CTC GTG GAT CCA RT-PCR
S16 +15/+38 S TCC GCT GCA GTC CGT TCA AGT CTT RT-PCR
S16 +376/+399 AS GCC AAA CTT CTT GGA TTC GCA GCG RT-PCR
Italic base indicates mutated nucleotide. S, sense; AS, antisense. RT-PCR, reverse transcription-polymerase chain reaction; EMSA, electromobility shift assay; ChIP,
chromatin immunoprecipitation.
doi:10.1371/journal.pone.0064316.t002
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30 min. Excess biotin was quenched by 50 mM NH4Cl at 4uC for
15 min. Cells were washed twice with ice-cold PBS and incubated
with vehicle or TGF-b1 at 35uC for various time points. Cells were
then washed twice with ice-cold PBS, and incubated with biotin
stripping buffer (100 mM Tris/HCl, pH 8.6, containing 50 mM
MESNA, 100 mM NaCl and 2.5 mM CaCl2) at 4uC for 30 min
and quenched with the quenching buffer (PBS/CM containing
iodoacetamide [5 mg/ml]) at 4uC for 15 min. Cell lysates were
harvested in IP lysis buffer (10 mM Tris, pH7.4, containing
0.15 M NaCl, 2 mM PMSF, 1 mM EGTA, 1% NP-40 [v/v],
1 mM sodium orthovanadate, leupeptin [1 mg/ml], aprotinin
[1 mg/ml] and 10% glycerol [v/v]). Biotinylated proteins were
isolated by incubating 700 mg of protein lysate with UltraLink
Immobilized NeutrAvidin Plus (Thermo Fisher Scientific) at 4uC
overnight. NeutrAvidin resin was washed with IP lysis buffer, and
biotinylated proteins were then extracted in SDS sample buffer.
Immunoblot analysis was performed to monitor the internalization
process of Necl-2.
Immunofluorescence Microscopy
GC-1 spg cells (1.36104 cells/cm2) were grown on Matrigel-
coated coverslips for 4 days. Vehicle or TGF-b1 was added 24 h
before harvest. For inhibitor studies, cells were pre-treated with
CHX (5 mg/ml, 30 min), followed by H2O or CPZ (12.5 mg/ml)
for 1 h before addition of cytokine. For clathrin knockdown
experiment, two different shRNAs (1 mg) were transfected using
Figure 1. Effects of TGF-b1 on Necl-2 expression and localization in GC-1 spg cells. Cells treated with vehicle (4 mM HCl/0.1%BSA) or TGF-
b1 (5 ng/ml) were subjected for RT-PCR (A) and Real-time PCR (B) analysis using primer specific for Necl-2 gene. For RT-PCR, b-actin was co-amplified
as an internal control. Necl-2 mRNA levels were normalized with b-actin. The authenticity of the PCR product was confirmed by sequencing analysis.
For real-time PCR, GAPDH was used as an internal control for normalization. (C) Necl-2 protein level was analyzed by Western Blotting. (D)
Immunofluorescence staining was performed in vehicle- and TGF-b1-treated cells. Cells were incubated with rabbit anti-Necl-2 antibody, followed by
goat anti-rabbit IgG conjugated with FITC. Necl-2 appeared as green fluorescent. DAPI was used for nuclear staining. Scale bar = 20 mm. Results of RT-
PCR, real-time PCR and Western blotting are expressed as the mean6S.D. of three independent experiments. ns, not significant vs vehicle control; *,
p,0.01 vs vehicle control; **, p,0.001 vs vehicle control.
doi:10.1371/journal.pone.0064316.g001
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Lipofectamine 2000 transfection reagent (Invitrogen) respectively.
At 48 h post transfection, cells were pre-treated with CHX,
followed by vehicle/TGF-b1 treatment for 24 h. Cells were fixed
with 4% paraformaldehyde and permeabilized with 0.3% Triton
X-100 for 20 min. Cells were then washed with PBS and blocked
with 10% normal goat serum for 1 h. This is followed by
incubation of anti-Necl-2 (1:50) overnight at 4uC. Cells were
washed with PBS before incubation with FITC-goat anti-rabbit
IgG (Zymed) or Alexa Fluor 555-goat anti-rabbit IgG (Molecular
Probes, Eugene, OR) for 1 h. Slides were mounted in Vectashield
Hardset with 49,69-diamino-2-phenylindole (DAPI) (Vector Lab-
oratories, Burlingame, CA). Images were acquired by Carl Zeiss
LSM 710 NLO confocal laser scanning microscope.
Data Analysis
Data were shown as means 6 S.D. of duplicate assays in three
independent experiments for RT-PCR, immunoblot and trans-
fection assays or means 6 S.D. of triplicate assays in three
independent experiments for real-time PCR. For EMSA and
ChIP, all experiments were repeated three times and consistent
results were obtained. For time-course experiments, statistical
analyses were performed using one-way ANOVA with Tukey’s
multiple comparison tests. For all other studies, Student’s t tests
were performed using software PRISM (GraphPad Software, Inc.,
San Diego, CA).
Results
TGF-b1 Reduces Necl-2 in both mRNA and Protein Levels
Since primary germ cells cannot culture healthy alone for more
than 1 day and show low transfection efficiency, we chose to use
germ cell line to delineate the molecular mechanism of how TGF-
b1 regulates Necl-2 expression. RT-PCR, real-time PCR and
Western blotting were performed to check whether TGF-b1
regulates Necl-2 expression in mouse germ cell line GC-1 spg cells.
Cells were treated with vehicle or TGF-b1 (5 ng/ml) at specified
time points. Both RT-PCR and real-time PCR analyses have
shown that TGF-b1 down-regulated Necl-2 mRNA levels in a
time-dependent manner (Fig. 1A and Fig. 1B). A time-dependent
reduction of Necl-2 protein level was also detected (Fig. 1C). Necl-
2 mRNA and protein levels were reduced by 35% and 60%
respectively after 24 h TGF-b1 treatment. The reduction of Necl-
2 protein levels was further confirmed by immunofluorescence
staining on TGF-b1-treated cells. It is apparent that Necl-2 is
localized at the cell-cell interface (Fig. 1D, upper panel). Upon
TGF-b1 treatment, no fluorescence signal could be detected
(Fig. 1D, lower panel), indicating that Necl-2 protein no longer
exists at the cell-cell interface. These results clearly suggested that
TGF-b1 is a potent negative regulator of Necl-2 expression.
TGF-b1 Reduces Necl-2 via Post-translational Regulation
Evidence has shown that post-translational regulation allows
rapid turnover of junction proteins at the blood-testis barrier,
which enables rapid restructuring of the cell junctions required for
progressive movement of developing germ cells in the epithelium
[27,31]. Apparently, TGF-b1 reduced Necl-2 protein significantly
and rapidly, we wonder if post-translational regulation plays a
crucial role in TGF-b1-mediated Necl-2 protein reduction. To test
this, cells were pre-treated with cycloheximide (CHX) for 30 min
to block protein synthesis, followed by vehicle or TGF-b1
treatment. As shown in Fig. 2A, TGF-b1 remains capable of
inducing a significant reduction of Necl-2 protein level (40%
reduction) in the presence of CHX when compared with vehicle
control. This result suggests that TGF-b1 reduces Necl-2 protein
level, at least in part, via promoting the turnover of Necl-2 protein.
TGF-b1 Promotes Necl-2 Protein Degradation via
Clathrin-dependent Endocytosis
To unravel the TGF-b1-induced Necl-2 protein degradation
pathway, various inhibitors were employed to block the protea-
some and endocytoic degradation pathways which are the two
major mechanisms reported for effective removal of cell junction
molecules from cell-cell interface [32]. MG132 (a proteasome
inhibitor), nystatin (an inhibitor of caveolin-dependent endocyto-
sis) and CPZ (an inhibitor of clathrin-mediated endocytosis) were
used prior to TGF-b1 treatment in order to screen the potential
degradation pathway. Pretreatment of two different doses of
MG132 (Fig. 2B) or nystatin (Fig. 2C) could not abolish the effect
of TGF-b1 on Necl-2 expression, indicating that TGF-b1-induced
Necl-2 degradation is not mediated via ubiquitin-proteasome
pathway or caveolin-dependent endocytosis. However, significant
rebound in Necl-2 protein level was observed when CPZ was
employed (Fig. 2D). Apart from the rebound of Necl-2 protein
level, re-localization of Necl-2 at the cell-cell interface was
observed in CPZ-pretreated cells in TGF-b1-treated group
(Fig. 2E). Western blotting analysis and immunofluorescence
staining unequivocally suggest that clathrin-mediated endocytosis
possibly involves in TGF-b1-induced protein degradation.
To further examine this possibility, two different clathrin
shRNAs were used to knockdown clathrin expression separately.
Both of these two clathrin shRNAs, but not sh-vector or sh-ctrl
construct, effectively reduced clathrin protein level (Fig. 3A). In the
parallel experiment, knockdown of clathrin significantly abrogated
TGF-b1-mediated Necl-2 reduction (Fig. 3A) as indicated by the
rebound of Necl-2 protein level in clathrin shRNA-transfected
group, but not in control shRNA one. Immunofluorescence
staining has also shown that Necl-2 remained at the cell-cell
interface in TGF-b1-treated cells that were transfected with
clathrin shRNA constructs, but not ctrl shRNA or sh-vector alone
(Fig. 3B). To monitor the internalization process of Necl-2 protein
upon TGF-b1 treatment, endocytosis assays were also performed.
It is apparent that TGF-b1 significantly induced the internaliza-
tion of Necl-2 as the level of biotinylated Necl-2 protein in cytosol
was significantly increased upon TGF-b1 stimulation when
compared to the corresponding control at 15 min and 30 min
(Fig. 3C). At 60 min after exposure to TGF-b1, the level of
cytosolic biotinylated Necl-2 protein declined accordingly, sug-
gesting that TGF-b1 accelerates the endocytosis of Necl-2,
Figure 2. Post-translational regulation of Necl-2 protein by TGF-b1 in GC-1 spg cells. (A) Necl-2 protein stability was analyzed by
cycloheximide assay. Cells were pre-treated with CHX (5 mg/ml, 30 min) before vehicle or TGF-b1 treatment. Western blotting was performed to
determine Necl-2 protein level. To determine the potential post-translational pathway, cells were pre-treated with CHX, followed by (B) proteasome
inhibitor MG132 for 30 min, (C) caveolin inhibitor nystatin for 30 min or (D) clathrin inhibitor CPZ for 1 h or 1.5 h prior to TGF-b1 treatment (24 h).
Necl-2 protein level was then analyzed by Western Blotting. (E) Immunofluorescence staining was performed in cells pretreated with CPZ followed by
vehicle or TGF-b1 treatment. Cells were incubated with rabbit anti-Necl-2 antibody, followed by goat anti-rabbit IgG conjugated with FITC. Necl-2
appeared as green fluorescent. DAPI was used for nuclear staining. Scale bar = 20 mm. A–D, Results are expressed as the mean6S.D. of three
independent experiments. ns, not significant vs vehicle control; *, p,0.01 vs vehicle control; **, p,0.001 vs vehicle control. CHX, cycloheximide; CPZ,
chlorpromazine.
doi:10.1371/journal.pone.0064316.g002
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followed by the degradation of endocytosed Necl-2 protein. Taken
together, inhibitor treatment, shRNA approach and endocytosis
assays have unequivocally demonstrated that TGF-b1 induces
Necl-2 protein degradation via clathrin-dependent endocytosis.
Transcriptional Regulation Plays a Role in TGF-b1-
induced Necl-2 reduction
Apart from post-translational regulation, TGF-b1 also reduced
Necl-2 mRNA by 35% (Fig. 1A and Fig. 1B), suggesting that
TGF-b1 reduces Necl-2 protein via its effect on Necl-2 mRNA.
To examine if TGF-b1 reduces Necl-2 mRNA level by destabi-
lizing Necl-2 mRNA transcript, cells were pre-treated with
actinomycin D for 2 h to block transcription prior to TGF-b1
treatment. RT-PCR and real-time PCR analyses have shown that
TGF-b1 caused no significant change on Necl-2 mRNA level in
the presence of actinomycin D when compared to vehicle control
(Fig. 4A and Fig. 4B). These results suggest that TGF-b1 down-
regulates Necl-2 mRNA level is not mediated via altering the
stability of Necl-2 transcript. To check whether TGF-b1 reduces
Necl-2 mRNA level via gene transcription, a series of luciferase
constructs having Necl-2 promoter region in different length were
generated. Cells were transfected with pGL-3 or luciferase
constructs and treated with vehicle or TGF-b1 for 18 h prior to
analyses. It was found that TGF-b1 caused a significant reduction
of Necl-2 promoter activity when cells transfected with p(-159/
21)Luc construct (Fig. 4C). Transfection of two other luciferase
constructs [p(-268/21)Luc and p(-502/21)Luc] showed similar
reductions of Necl-2 promoter activities upon TGF-b1 treatment
(Fig. 4C), suggesting that the promoter region between nt -159 and
-1 contains crucial cis-acting elements that are responsible for
TGF-b1-induced Necl-2 gene repression.
MyoD and Two CCAAT Motifs are Required for TGF-b1-
mediated Necl-2 Gene Repression
MyoD, CCAATa and CCAATb motifs were identified within
the sequence between nt -159 and -1 by computational analyses
using Matlnspector (Genomatrix Software Inc., Ann Arbor, MI)
and TFsearch (Parallel Application TRC Laboratory, Japan)
(Fig. 4D, upper panel). Mutated luciferase constructs were
generated and transfected into the cells followed by TGF-b1
treatment. As shown in Fig. 4D, single mutation of either MyoD,
CCAATa or CCAATb motif abolished TGF-b1-induced Necl-2
gene repression. Also, the double and triple mutants exerted
similar rebound effect. These results suggest that MyoD, CCAATa
and CCAATb motifs might play important roles in TGF-b1-
mediated Necl-2 gene repression. It is worth mentioning that
concurrent mutation of MyoD, CCAATa and CCAATb caused
no Necl-2 promoter activity, suggesting that these three motifs
work in concert to drive the basal Necl-2 gene transcription.
TGF-b1-induced Necl-2 Gene Repression Requires the
Activation of Smad Signaling Pathway and the
Involvement of MyoD and CCAAT Motifs
It is well-known that Smads are classical downstream molecules
of TGF-b signaling cascade. To test if Smad proteins were
involved in TGF-b1-induced Necl-2 repression, two si-Smad3
and/or si-Smad4 with different target sequences were used (see
Table 1) to knockdown the expression of Smad proteins. Co-
transfection of si-Smad3 (si-Smad3#1 or si-Smad3#2) and/or si-
Smad4 (si-Smad4#1 or si-Smad4#2) with p(-159/21)Luc abol-
ished TGF-b1-mediated reduction of Necl-2 promoter activity
when compared to the corresponding si-buffer or si-ctrl (Fig. 4E),
suggesting that down-regulation of Necl-2 promoter activity
requires Smad proteins. In the parallel experiment, the level of
Smad3 and Smad4 proteins after introduction of si-Smad3 and si-
Smad4 in cells were examined by immunoblotting (Fig. 4E, upper
panel).
To determine the cis-acting motifs involved in TGF-b1/Smads-
induced Necl-2 gene repression, overexpression of Smad proteins
with p(-159/21)Luc or its mutant constructs carrying mutation on
the respective cis-acting motifs were performed. Transfection of
either Smad3 or Smad4 overexpression constructs with wild-type
p(-159/21)Luc, or mutant constructs including p(-159/
1)CCAATa* and p(-159/1)CCAATb* caused similar degree of
reduction in Necl-2 promoter activity when compared with pGL-3
vector, whereas Smad 3 or Smad4 overexpression with p(-159/
21)MyoD* caused a partial rebound in Necl-2 promoter activity
when compared to wild-type construct (Fig. 4F). Co-transfection of
Smad3 and Smad4 could induce a more significant rebound of
Necl-2 promoter activity in both p(-159/21)MyoD* and p(-159/
1)CCAATa* constructs when compared to that with Smad3 or
Smad4 overexpression alone (Fig. 4E). These results suggest that
MyoD is a crucial motif for Smad-mediated Necl-2 gene
repression and CCAATa motif works in concert/assists with
MyoD motif in mediating TGF-b1-induced Necl-2 gene repres-
sion.
TGF-b1 Induces the Binding of Smad Proteins to MyoD
and CCAATa Motifs in vitro and in vivo
To determine the binding of Smad proteins with the cis-acting
motifs, EMSAs were performed. EMSAs have shown that DNA-
protein complexes (complexes A–C) were formed dose-depen-
dently when radiolabeled MyoD or CCAATa probes were
incubated with increasing amount of nuclear extract, and the
specificities of the complexes were confirmed by cold competition
assays (Fig. 5A and 5D). Antibody supershift assays indicated that
NF-1, but not MyoD or Smad proteins, was the transcription
factor bound to MyoD motif in untreated condition (vehicle
control) as the formation of complex A diminished in the presence
of NF-1 antibody (Fig. 5B). However, a change in the binding
component of transcription factors to MyoD motifs upon TGF-b1
Figure 3. Effect of clathrin-shRNA on Necl-2 protein level and endocytosis assay. (A) Cells were transfected with sh-vector, sh-ctrl or sh-
clathrin (#1 and#2) (1 mg) for 48 h, subsequently treated with CHX, followed by vehicle or TGF-b1 treatment. Level of clathrin, Necl-2 and actin were
analysed by Western blotting. Actin was used as an internal control. Necl-2 protein levels were normalized with actin. (B) Immunofluorescence
staining was performed in cells transfected with sh-vector, sh-ctrl or sh-clathrin followed by vehicle or TGF-b1 treatment. Cells were incubated with
rabbit anti-Necl-2 antibody, followed by goat anti-rabbit IgG conjugated with Alexa Fluor 555. Necl-2 appeared as red fluorescent. DAPI was used for
nuclear staining. Scale bar = 20 mm. (C) GC-1 spg cells were biotinylated for 30 min. Cells were then incubated with either vehicle or TGF-b1 at 35uC
to allow endocytosis, and reactions were terminated at various time points. Total = total labeled cell surface protein without stripping. Cell surface
protein without biotinylation served as the negative control. Biotinylated proteins were pulled down by UltraLink Immobilized NeutrAvidin Plus
beads and were subjected to Western blotting. Equal amounts of proteins were used at each time points as assessed by Actin blot. Percentage of
internalized and biotinylated proteins remaining in the cytosol in the presence of vehicle or TGF-b1 are shown. The percentage of internalized and
biotinylated Necl-2 at time 0 was arbitrarily set at 100. Results are expressed as the mean6 S.D. of three independent experiments. ns, not significant
vs corresponding vehicle control; **, p,0.001 vs corresponding vehicle control. CHX, cycloheximide; Veh, vehicle control.
doi:10.1371/journal.pone.0064316.g003
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treatment was observed. TGF-b1 promoted the binding of Smad3
and Smad4 to the MyoD motif when cells were treated with TGF-
b1 (Fig. 5C, lanes 2–4 vs 5B, lanes 1, 4 & 5). For CCAATa motif,
two specific DNA-protein complexes (B and C) were observed in
vehicle control (Fig. 5D). Apparently, NF-1 was the major
component of these complexes when vehicle-treated nuclear
extracts were used (Fig. 5E). When TGF-b1-treated nuclear
extracts were used, we detected an increase in the formation of
complex B and a reduction in the formation of complex C (Fig. 5F,
lane 2 vs lane 1), suggesting that complex B might act as a negative
regulatory complex. Furthermore, antibody supershift assays
showed that Smad3 and Smad4 are the components of complex
B when TGF-b1-treated nuclear extracts were used (Fig. 5F, lane
2 vs lanes 3 & 4). These results indicated that NF-1 is the
transcription factor that normally binds to the MyoD and
CCAATa motifs for basal gene transcription, while TGF-b1
induces the binding of Smad3 and Smad4 that negatively regulates
Necl-2 gene transcription via competitive binding on MyoD and
CCAATa motifs. In addition, ChIP assays were conducted to
further confirm the in vivo interaction of Smad proteins with Necl-
2 promoter (Fig. 5G) as indicated by the amplification of 349 bp
PCR band using A287 and A288 primers, but not A107 and A108
primer pair. Taken together, these results suggest that TGF-b1
induces the binding Smad3 and Smad4 to MyoD and CCAATa
motifs in vitro and in vivo and thus exerts negative regulatory effect
on Necl-2 gene transcription.
Discussion
Sertoli cells play crucial roles in paracrine regulation of
spermatogenesis by providing growth factors and cytokines to
developing germ cells. Besides, physical interactions between
developing germ cells and between Sertoli-germ cells via cell
junctions in nurturing the development of germ cells as such
interaction provides physical and structural support to developing
germ cells. Knockout studies indicated that Necl-2 mediates
Sertoli-germ and germ-germ cell interactions that are essential for
spermatogenesis. Necl-2 null male mice are infertile with defects in
spermatozoa [20–23]. Previous study revealed that Necl-2 mRNA
could only be detected in spermatogonia and early pre-meiotic
spermatocytes [14]. Subsequent studies have found that Necl-2
protein is expressed on type A spermatogonia through to early
pachytene spermatocytes, as well as step 5 to late spermatids
[17,18]. Researchers have speculated that transcription of Necl-2
terminates in early pre-meiotic spermatocytes, while translation
restarts in spermatids using mRNA that was synthesized in per-
meiotic germ cells [17]. In this study, we have unraveled the
potential mechanism on how Necl-2 transcription is terminated
and how Necl-2 protein at the cell-cell interface is internalized and
degraded. We found that TGF-b1 is a potent cytokine that
mediates transcriptional repression of Necl-2 gene in GC-1 spg
cells. Apparent, this could be an effective mechanism to terminate
the transcription of Necl-2 gene in early pre-meiotic germ cells. It
is of interest to point out that the existing Necl-2 mRNA
transcripts remain very stable even after TGF-b1 treatment in
the actinomycin D study, which fits the hypothesis that the mRNA
synthesized in early stage of germ cell development with long half-
life may be used for protein translation in spermatids.
In examining the details of transcriptional mechanism, we found
that NF-1 interacts with both MyoD and CCAATa motifs and
thus functions as a positive regulator to mediate the transcription
of Necl-2 gene in normal condition (vehicle-control). Overexpres-
sion of NF-1 showed that NF-1-A and NF-1-B positively regulate
Necl-2 gene transcription (Fig.S1). Upon TGF-b1 stimulation,
there is a change in the components of transcription factors that
bind to MyoD and CCAATa motifs. TGF-b1 indeed activates
Smad pathway and promotes the binding of Smad proteins to
MyoD and CCAATa motifs. It was different from that in vehicle
control group where anti-Smad antibodies were not able to
diminish the formation of complexes A and B, suggesting that the
binding of Smad proteins to these two motifs is TGF-b1-
dependent. It is apparent that Smad proteins compete successfully
against with NF-1 for MyoD motif and CCAATa motif (complex
B) in the presence of TGF-b1, resulting in negative regulation. In
addition, TGF-b1 promotes the formation of complex B where
Smad proteins binds to, while it partly inhibits the formation of
complex C where the positive regulator, NF-1, binds onto (Fig. 5F).
The reduced amount of positive regulator bound to the respective
motifs may also serve as another mechanism in mediating gene
repression.
Mutational studies have shown that single mutation of
CCAATb motif abolish the effect of TGF-b1 on Necl-2 gene
transcription (Fig. 4D), suggesting that CCAATb motif might also
be involved in TGF-b1-mediated Necl-2 gene repression. How-
ever, overexpression of Smad proteins coupled with mutational
analyses (Fig, 4F) and EMSA performed using CCAATb probe
(data not shown) have demonstrated that the negative regulators
(Smad proteins) do not directly interact with CCAATb motif in
triggering TGF-b1-mediated Necl-2 gene repression. Although
Smad proteins do not bind to CCAATb motif, we cannot rule out
the possibility that CCAATb motif may assist Smad proteins
bound onto MyoD and CCAATa motifs via its involvement in
proper looping of Necl-2 promoter region. In short, there is a
functional cooperation between MyoD and CCAATa motifs in
initiating TGF-b1-mediated Necl-2 gene repression.
Apart from TGF-b1-mediated Necl-2 gene repression, we also
found that TGF-b1 reduces Necl-2 protein level via post-
translational regulation. TGF-b1 promotes the degradation of
Necl-2 protein appeared on germ cells via clathrin-mediated
endocytosis. Both inhibitor (CPZ) treatment (partially rebound in
Figure 4. Effect of TGF-b1 on Necl-2 mRNA stability and promoter activity. (A) and (B) Analysis of Necl-2 mRNA stability was performed by
actinomycin D (ActD) assay. Cells were pre-treated with ActD (5 mg/ml) for 2 h before vehicle or TGF-b1 treatment. RT-PCR (A) and real-time PCR (B)
were performed to determine Necl-2 mRNA level. (C) Progressive 59-deletion analysis of mouse Necl-2 promoter was performed between nt -502 and
-1. A series 59-deletion constructs and pEGFP vector were co-transfected into GC-1 spg cells followed by TGF-b1 treatment (5 ng/ml, 18 h). (D) Three
putative cis-acting elements including MyoD, CCAATa and CCAATb motifs are located within the region between nt -159 and -1 (upper panel). Site-
directed mutagenic constructs containing single, double or triple mutations and pEGFP vector were co-transfected into GC-1 spg cells followed by
TGF-b1 treatment. pEGFP activity was used to normalize transfection efficiency. Promoter activity was represented as the fold change when
compared with pGL-3 vector. (E) pGL-3 vector, p(-159/21)Luc and pEGFP vector were co-transfected with si-Smad3 (#1/#2, 20 nM) or/and si-Smad4
(#1/#2, 20 nM) for 48 h followed by TGF-b1 treatment. pEGFP activity was used to normalize transfection efficiency. Smad3 and Smad4 protein
levels were examined by Western blotting. (F) Wild-type and single mutated constructs of p(-159/21)Luc were co-transfected with pcDNA3.1 vector,
Smad3 or/and Smad4 expression constructs into GC-1 spg cells. The promoter activity was presented as a percentage of that of pcDNA3.1-
transfected cells. (A–F), Results are expressed as the mean6S.D. of three independent experiments. ns, not significant vs vehicle control (A–E) or p(-
159/21)Luc (F); *, p,0.01 vehicle control (A–E) or vs p(-159/21)Luc (F); **, p,0.001 vs vehicle control (A–E) or p(-159/21)Luc (F). ActD, actinomycin
D.
doi:10.1371/journal.pone.0064316.g004
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1-hr CPZ incubation and completely rebound in 1.5-hr CPZ
incubation) and shRNA knockdown studies have unequivocally
demonstrated the involvement of clathrin in TGF-b1-mediated
Necl-2 protein degradation. In addition, endocytosis assays further
confirmed that TGF-b1 accelerates the kinetic of Necl-2
internalization and thus leads to Necl-2 degradation. Furthermore,
immunofluorescence staining clearly revealed that Necl-2 was
significantly declined from cell-cell interface upon TGF-b1
treatment, whereas Necl-2 remained at the cell-cell interface in
the cells transfected with clathrin shRNA construct. These data
suggest that TGF-b1 might perturb cell-cell interaction via
internalizing Necl-2 from cell surface via endocytosis. Although
this study was performed in spermatogonial cells, it is of
importance as mature germ cell line is not available and primary
germ cells cannot be cultured alone to perform in-depth
mechanistic studies. Therefore, our current studies provide a
blueprint in understanding how TGF-b1 might exert its effect in
promoting the detachment of germ cells from seminiferous
epithelium via disrupting Necl-2-based cell junction complexes.
In summary, we unraveled two mechanisms by which TGF-b1
exerts its effect on Necl-2 protein expression in germ cells that are
crucial for Sertoli-germ and germ-germ cell interaction in
spermatogenesis. TGF-b1 promotes the binding of Smad proteins
to MyoD and CCAATa motifs, causing Necl-2 gene repression.
Also, it induces the internalization of Necl-2 protein from cell-cell
interface via clathrin-dependent endocytosis, thus promoting Necl-
2 protein turnover.
Supporting Information
Figure S1 Changes in the mRNA levels of TGF-b1 and
Necl-2 in staged seminiferous tubules and effect of NF-1
on Necl-2 promoter activity. pCH vector, pCH-NF-1A and
pCH-NF-1B were co-transfected with pGL-3 or p(-159/21)Luc
construct into GC-1spg cells. pEGFP activity was used to
normalize transfection efficiency. Promoter activity was represent-
ed as the fold change when compared with pGL-3 vector. Results
are expressed as the mean6S.D. of three independent experi-
ments. **, p,0.001 vs pCH vector.
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